1)mutational P53突变P53
2)mutant p53突变型p53
1.Correlation and potential interaction between FHIT and mutant P53 expression in non-small cell lung cancer;非小细胞肺癌组织FHIT和突变型P53表达的关联性及相互作用
2.Effects of Baicao Jiangzhiling on the Expression of PCNA and Mutant p53 in the Atherosclerotic Rabbit;百草降脂灵对动脉粥样硬化兔腹主动脉PCNA及突变型p53表达的影响
3.The expression and clinical significance of mutant p53,bcl-2,Ki-67,survivin in non-Hodgkin' s lymphoma(NHL)非霍奇金淋巴瘤组织中突变型p53、bcl-2、Ki-67及survivin蛋白表达及临床意义
英文短句/例句
1.The Study of Dnazyme in Inhibiting Mutant p53 Gene Expression in Vitro;脱氧核酶抑制突变型p53基因表达的体外研究
2.Expressions of VEGF and mutant p53 gene and their clinical significance in patients with gastric carcinoma胃癌中VEGF及突变型p53基因表达及临床意义研究
3.EXPRESSION AND SIGNIFICANCE OF MUTANT p53,MDM2 AND CASPASE-3 IN NON-SMALL CELL LUNG CANCER突变型p53、MDM2、caspase-3在非小细胞肺癌的表达及意义
4.The study of disseminated tumor cell(DTC)and p53 gene in mouse model of laryngocarcinoma喉癌动物模型中播散肿瘤细胞与突变型p53的研究
5.Research on Expression of hMLH1 and p53 in Sporadic Colorectal Carcinoma and Colorectal Adenoma;散发性结直肠癌、腺瘤组织中hMLH1和突变型p53表达的研究
6.Expression and Clinical Significance of P27～(kip1) and Mutated p53 in Testicular Seminoma;P27～（kip1）和突变型p53在睾丸精原细胞瘤中表达及其临床意义的研究
7.Expression of hMSH2、hMLH1 and P53 in Sporadic Colorectal Carcinoma;错配修复基因hMSH2、hMLH1与突变型p53在散发性大肠癌中的表达
8.Clinicopathological Significance of Maspin and Mutant p53 Protein Expression in Gastric Cancer;胃癌中maspin和突变型p53蛋白的表达及临床病理学意义
9.Expression of iNOS and Mutational p53 Protein and Correlation between Them in Ovarian Neoplasm;卵巢肿瘤组织中突变型p53表达与iNOS活性及二者相关性的研究
10.Expressions of COX-2 Protein and Mutable p53 Protein in Breast Cancer and Their Clinical SignificanceCOX-2蛋白与突变型p53蛋白在乳腺癌组织中的表达及临床意义
11.Expressions of mutant p53,Mdm2 and PCNA protein in gastric mucosal lesions and their relationship with Helicobacter pylori infection胃黏膜病变中突变型p53、Mdm2和PCNA蛋白表达及与幽门螺杆菌感染的关系
12.Expression of mtP53 and HSP70 in Epithelial Ovarian Carcinoma and Clinical Value;HSP70、突变型P53在卵巢癌中的表达及临床意义
13.Study the Relation between Mutatant p53 and Multidrug Resistance in Gastric Cancer;突变型P53与胃癌多重耐药性关系的研究
14.Relationship between mutant P53 and hMLH1 in the carcinogenesis of colorectal carcinoma大肠癌发生中突变型P53与hMLH1表达的关系
15.Effect on the Function of 249 Arg to Ser Mutation in the p53 Genep53基因249编码子突变对p53功能的影响
16.Comparison of p53 Wild-type and Mutated Clinicopathological Characteristics in Epithelial Ovarian Cancerp53野生型与突变型上皮性卵巢癌临床病理特征比较
17.The Expression of PAX2 and Mutant P53 in Endometrial Carcinoma and Its Clinical Significance;PAX2和突变型P53在子宫内膜癌中的表达和临床意义
18.Significance of Mutant P53 Protein in Cervical Cancer before and after Arterial Interventional Chemotherapy;突变型P53蛋白在宫颈癌动脉介入化疗前后的表达意义
相关短句/例句
mutant p53突变型p53
1.Correlation and potential interaction between FHIT and mutant P53 expression in non-small cell lung cancer;非小细胞肺癌组织FHIT和突变型P53表达的关联性及相互作用
2.Effects of Baicao Jiangzhiling on the Expression of PCNA and Mutant p53 in the Atherosclerotic Rabbit;百草降脂灵对动脉粥样硬化兔腹主动脉PCNA及突变型p53表达的影响
3.The expression and clinical significance of mutant p53,bcl-2,Ki-67,survivin in non-Hodgkin' s lymphoma(NHL)非霍奇金淋巴瘤组织中突变型p53、bcl-2、Ki-67及survivin蛋白表达及临床意义
3)mtP53突变型P53
1.Expression of PTEN and mtP53 Gene in epithelial ovarian cancer.;上皮性卵巢癌磷酸酶-张力蛋白和突变型P53表达的临床意义
4)p53 mutationp53突变
1.The research of plasma p53 mutation in hepatocellular carcinoma patients from Qidong high risk area.;启东肝癌高发区肝癌患者血清中p53突变研究(英文)
2.Analysis of p53 mutations in radiation induced transformed RTE cells by PCR SSCP.;PCR-SSCP技术检测辐射诱发的恶转细胞p53突变
3.Using single strand conformational polymorphism(SSCP) and DNA sequencing,p53 mutation was detected in 82 cases of soft tissue sarcoma,including 40 cases of special chromosomal translocation-associated soft tissue sarcoma and 42 cases of nontranslocation-associated soft tissue sarcoma.研究特异性染色体易位相关与非相关软组织肉瘤间p53突变情况及差异。
5)p53 mutation spectrump53突变谱
6)p53 mutationp53 突变
延伸阅读
[trans,trans]-4-(4-Pentylcyclohexyl)-4'-(4-propylcyclohexyl)-1,1'-biphenyl CBC53CAS：80955-71-1分子式：C32H46分子质量：430.71中文名称：[反,反]-4-(4-戊基环己基)-4'-(4-丙基环己基)-1,1'-联苯；ZLI-1544英文名称：[trans,trans]-4-(4-Pentylcyclohexyl)-4'-(4-propylcyclohexyl)-1,1'-biphenyl CBC53
